Connection
Nicholas Foreman to Ipilimumab
This is a "connection" page, showing publications Nicholas Foreman has written about Ipilimumab.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.058 |
|
|
|
-
Dunkel IJ, Doz F, Foreman NK, Hargrave D, Lassaletta A, Andr? N, Hansford JR, Hassall T, Eyrich M, Gururangan S, Bartels U, Gajjar A, Howell L, Warad D, Pacius M, Tam R, Wang Y, Zhu L, Cohen K. Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908. Neuro Oncol. 2023 08 03; 25(8):1530-1545.
Score: 0.058